Mark J. Forchette

As president and chief executive officer of Delphinus Medical Technologies, Mark leads a team that has created an innovative whole breast ultrasound imaging device called SoftVue that is designed to find more cancer in dense breast screening than mammography alone through enhanced tissue characterization, leveraging streamlined workflow & unparalleled patient comfort with NO additional compression or radiation. Delphinus is a privately held medical technology company founded in 2010 and located in Novi, Michigan.

Mark has more than 35 years of experience leading innovative medical device companies to transform patient care and earn market leadership positions. Prior to joining Delphinus, Mark served as president and chief executive officer at OptiMedica Corp., a Silicon Valley based ophthalmic medical device company. He led the start-up venture through development and growth, completed multiple rounds of financing, and oversaw the company’s acquisition by Abbott Laboratories in 2013. He began his career in the medical technology industry as a sales representative at Grieshaber and Company, Inc., where he ultimately became vice president of U.S. sales and marketing and led the company through its acquisition by Alcon. During his tenure at Alcon, he led the retina business unit to substantial global share growth and advanced to vice president of vitreoretinal sales and global marketing.

Mark is a director on the Auburn University Foundation Board, serves on the Harbert College of Business Dean’s Advisory Council at Auburn University and is the creator of the idea behind the Harbert College of Business’s Tiger Cage, Top Tigers, and the Entrepreneurial Summit.

Mark has a bachelor’s degree in marketing from Auburn University and completed the Harvard Program for Management Development.